Novo Nordisk Completes Share Repurchase Program

Ticker: NONOF · Form: 6-K · Filed: Jan 21, 2025 · CIK: 353278

Sentiment: neutral

Topics: share-repurchase, capital-return

TL;DR

Novo Nordisk just finished buying back DKK 4B in stock, last trade Jan 17.

AI Summary

Novo Nordisk A/S announced on January 20, 2025, that it has completed a share repurchase program initiated on November 11, 2024. The company repurchased a total of 10,000,000 shares under this program, with the last transaction occurring on January 17, 2025. The total cost of the repurchased shares was approximately DKK 4,000,000,000.

Why It Matters

The completion of this share repurchase program indicates Novo Nordisk's commitment to returning capital to shareholders and potentially supports its stock price.

Risk Assessment

Risk Level: low — This filing is a routine report on a completed share repurchase program, with no new material risks introduced.

Key Numbers

Key Players & Entities

FAQ

What was the total number of shares repurchased under the program?

Novo Nordisk repurchased a total of 10,000,000 shares under the program.

What was the total cost of the share repurchase program?

The total cost of the repurchased shares was approximately DKK 4,000,000,000.

When was the share repurchase program initiated?

The share repurchase program was initiated on November 11, 2024.

When was the last transaction under the share repurchase program?

The last transaction under the share repurchase program occurred on January 17, 2025.

What regulation governs this share repurchase program?

The share repurchase program is in accordance with Article 5 of Regulation No 596/2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052.

Filing Stats: 618 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2025-01-21 06:05:05

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf of the undersigned, thereunto duly authorized. Date: January 20, 2025 NOVO NORDISK A/S Lars Fruergaard Jørgensen Chief Executive Officer

View Full Filing

View this 6-K filing on SEC EDGAR

View on Read The Filing